Showing results (1161-1170 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|September 18, 2018
Role of omega-3 polyunsaturated fatty acids in preventing gastrointestinal cancers: current status and future perspectivesHo-Jae Lee, Young-Min Han, Jeong Min An, et al.Expert Review of Anticancer Therapy|September 19, 2018
Recurrent ovarian cancer 8 months after induction and bevacizumab consolidation: rationale for using trabectedin + pegylated liposomal doxorubicin in second lineNicoletta ColomboExpert Review of Anticancer Therapy|September 19, 2018
Trabectedin + pegylated liposomal doxorubicin in third-line treatment of platinum-sensitive relapsed ovarian cancer: a case studyChristian MarthExpert Review of Anticancer Therapy|April 13, 2019
Rucaparib in the landscape of PARP inhibition in ovarian cancerEmeline Colomba, Patricia Pautier, Fanny Pommeret, et al.Expert Review of Anticancer Therapy|October 12, 2018
Nivolumab for the treatment of hepatocellular carcinomaFabian Finkelmeier, Oliver Waidmann, Joerg TrojanExpert Review of Anticancer Therapy|May 24, 2017
Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatmentArchana Anantharaman, Eric J SmallExpert Review of Anticancer Therapy|May 25, 2018
Nivolumab for the treatment of colorectal cancerKortnye Maureen Smith, Jayesh DesaiExpert Review of Anticancer Therapy|June 1, 2018
Therapeutic strategies for upper tract urothelial carcinomaYuval Freifeld, Laura-Maria Krabbe, Timothy N Clinton, et al.Expert Review of Anticancer Therapy|November 27, 2018
The molecular characterization and therapeutic strategies of papillary renal cell carcinomaQiwei Chen, Liang Cheng, Quanlin LiExpert Review of Anticancer Therapy|December 30, 2017
Pembrolizumab for the treatment of bladder cancerNora Sundahl, Sylvie Rottey, Daan De Maeseneer, et al.Pageof 310